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ABSTRACT
Objective Recent randomised clinical trials among
stable HIV sero-discordant couples (SDCs) in sub-
Saharan Africa (SSA) have reported that about 20–30%
of new HIV infections are acquired from external sexual
partners, rather than transmitted from the infected to the
uninfected partner within the couple. The aim of this
study is to examine whether, and to what extent, these
ﬁndings are generalisable to SDCs in the wider
population in SSA.
Methods A mathematical model was constructed to
calculate the fraction of new HIV-1 infections among
SDCs that are due to sources external to the couple. The
model was parameterised using empirical and population-
based data for 20 countries in SSA. Uncertainty and
sensitivity analyses were also conducted.
Results The contribution of external infections among
SDCs was generally modest, but it varied widely across
SSA. In low HIV prevalence countries (≤3.0%), it ranged
from 0.6–2.9%. In intermediate prevalence countries
(3.0–18.0%), it ranged from 4.9–11.7%. In Swaziland and
Lesotho, the world’s most-intense epidemics, sizable
levels of 27.9% and 27.3% were found, respectively.
Conclusions In most countries in SSA, nearly all HIV
acquisitions by the uninfected partners in SDCs appear to
be due to transmissions from the HIV infected partners
in the SDCs. The contribution of externally acquired
infections varies with HIV population prevalence, but
rarely exceeds 10% in the majority of countries. Only in
hyperendemic HIV epidemics the contribution of external
infections is substantial and may reach the levels
reported in recent randomised clinical trials involving
SDCs.
INTRODUCTION
Recent randomised controlled clinical trials (RCTs)
among stable HIV sero-discordant couples (SDCs)
have reported that about 20–30% of new HIV
infections among these SDCs were acquired from
external sexual partners, rather than transmitted
from the infected to the uninfected partner within
the couple.1 2 In these trials, viral linkages
between study-partner pairs were established
through phylogenetic analyses and gene sequen-
cing for the C2-V3-C3 regions of the env gene1 or
the HIV-1 pol gene.2 The probability of linkage
was determined either through measuring the pair-
wise nucleotide distances between the sequences,1
or by using Bayes’ theorem to compare the genetic
similarity of HIV-1 from partner pairs with the
genetic similarity of HIV-1 from local control
subjects.2
The conditions under which these trials were
conducted, with sero-status disclosure and counsel-
ling, pose a question about the generalisability of
the trials’ ﬁndings to other SDCs within the wider
population. This issue has recently received much
attention in light of the debate about the contribu-
tion of HIV sero-conversions among SDCs to the
HIV epidemic in sub-Saharan Africa (SSA).3–5
Against this background, we constructed a math-
ematical model parameterised by state of the art
empirical data to calculate the population-level
fraction of new HIV-1 infections among SDCs
that are due to sources external to the couple in 20
countries in SSA.
METHODS
Model structure
The annual risk of HIV transmission from the
infected to the uninfected partner within an SDC
(ϕ) is determined by HIV transmission probability
per coital act (p), the number of coital acts per
year (n), the fraction of coital acts protected by
condom use (fcondom), the efﬁcacy of condom use
in preventing HIV transmission per sexual act
(Econdom), and whether the susceptible partner in
the couple is a circumcised male. In a couple
where the male is not circumcised, ϕ is given by:
f¼1ð1pÞð1fcondomÞnð1ð1EcondomÞpÞfcondomn:
The average ϕ in the population is determined as a
weighted average of the annual risk of HIV transmis-
sion among SDCs with and without male circumci-
sion (see supplementary online appendix (SOA)).
Let λ be the annual risk of the HIV sero-negative
individual in an SDC to acquire the infection from
a source external to the couple. We assume that
the annual risk of any susceptible individual in the
population to acquire the infection, that is, the
hazard rate of infection or incidence rate, is
approximately equal among those individuals in
stable couples versus those not in stable couples,
and is also approximately equal among those in
HIV concordant negative couples versus those in
SDCs. Accordingly, λ can be approximated by HIV
population-level incidence rate. While the strict
validity of this assumption is not known, existing
empirical data discussed below suggests its plausi-
bility. Moreover, potential violations of this
assumption are more likely than not to afﬁrm our
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conclusion regarding the contribution of external infections.
Further considerations regarding this assumption and its varia-
tions are in the Discussion section.
Based on this assumption and using competing hazards, that
is, comparing the likelihood of acquiring the HIV infection
from an external source to the likelihood of acquiring the infec-
tion from the infected partner in an SDC, the fraction of new
HIV-1 infections among SDCs that are due to sources external
to the couple (fext) is given by fext= λ/(λ+ϕ). Further mathem-
atical derivations can be found in SOA.
Model parameterisation
We used the most recent Demographic and Health Survey
(DHS) databases for 20 countries in SSA6 to calculate the
country-speciﬁc: HIV prevalence (P), fraction of HIV-infected
females among the SDCs (findex), fraction of circumcised males
in SDCs with HIV-infected females (fmc), and condom use
at last sexual act among stable couples (fcondom) (see table S1
in SOA). HIV population-level incidence rate was obtained
from the Joint United Nations Programme on HIV/AIDS
SPECTRUM model predictions for each country for the
speciﬁc year of the DHS survey (Gouws E, Joint United
Nations Programme on HIV/AIDS (UNAIDS). Personal
Communication. 2011).7 For countries where SPECTRUM
model predictions are not available, or where the bounds of the
95% CI are not precisely speciﬁed, estimates for HIV incidence
rate were derived using the DHS country-speciﬁc HIV-1 preva-
lence (SOA). We calculated p as the average from the Rakai
Study8 and the Partners in Prevention Study (Hughes JP.
Personal communication. 2010),1 9 and derived n from the
Rakai Study8 as data on frequency of coital acts were not avail-
able in the DHS databases from which we derived these mea-
sures. We opted to use n in the Rakai Study because this choice
implies values for ϕ that are consistent with the existing empir-
ical measures, and in fact are at the mid-range of these esti-
mates.8–10 Further discussion of the model parameters can be
found in SOA.
Uncertainty and sensitivity analyses
An uncertainty analysis was conducted to generate country-
speciﬁc likelihood distributions for fext using Monte Carlo sam-
pling from the uncertainty ranges of p, n, country-speciﬁc λ,
country-speciﬁc findex, country-speciﬁc fmc, country-speciﬁc
fcondom, Econdom, and the efﬁcacy of male circumcision in pre-
venting HIV acquisition among susceptible males (Emc). The
distributions were used to calculate the country-speciﬁc means
and 95% CIs of fext across SSA. Further description of the
uncertainty analysis can be found in SOA.
To explore the impact of alternative assumptions to our
model assumptions, we conducted a sensitivity analysis for fext
by varying ϕ and λ over a range starting from half to twice the
values for these measures (ﬁgure 1B). We also conducted an
additional sensitivity analysis where we examined the variation
of fext across a spectrum of values for λ and ϕ (section IV and
ﬁgure S1 of SOA).
Figure 1 Fraction of new HIV-1 infections among stable HIV-1 sero-discordant couples that are due to sources external to the couple (fext) across
sub-Saharan Africa (SSA). (A) Country-speciﬁc means and 95% CIs for fext across 20 countries in SSA. (B) Country-speciﬁc ranges for fext using a
sensitivity analysis on our model assumptions. Countries are shown in order of increasing HIV-1 prevalence. This ﬁgure is only reproduced in colour
in the online version.
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RESULTS
Figure 1A and online supplementary table S1 show the esti-
mates for the country-speciﬁc fext. In low HIV prevalence coun-
tries (≤3.0%), fext had a range of 0.6–2.9%. In intermediate
prevalence countries (3.0–18.0%), the range was 4.9–11.7%. In
Swaziland and Lesotho, the world’s most-intense epidemics,
high levels of 27.9% and 27.3% were found, respectively. The
uncertainty analysis showed narrow CIs particularly in low to
intermediate HIV prevalence countries (ﬁgure 1A). The sensi-
tivity analyses showed that overall fext is unlikely to exceed
30% even with extreme variations in our model assumptions,
and that for most countries fext is no more than just few per-
centage points (ﬁgure 1B and ﬁgure S1 of SOA).
DISCUSSION
In most countries in SSA, nearly all new HIV acquisitions by
the uninfected partners in SDCs appear to be due to transmis-
sions from the HIV infected partners in the SDCs. The contri-
bution of external infections to SDCs is minimal and
substantially lower than what has been observed recently in
RCTs involving SDCs.1 2
However, the risk of HIV acquisition from external partners
varies across SSA, and depends strongly on HIV prevalence in the
population (ﬁgure 1). While less than 3% of HIV infections are
from external partners in low prevalence countries, as much as
12% of infections are externally acquired in intermediate preva-
lence countries. Moreover, in the high-prevalence countries of
Swaziland and Lesotho, the contribution of external partnerships
reaches sizable levels, comparable to those measured in the
RCTs.1 2 These ﬁndings were found robust to the limitations in
our knowledge of some of the model parameters as the uncer-
tainty analysis in ﬁgure 1A demonstrates.
We have tested our model by applying it to a speciﬁc site with
robust empirical data: Rakai, Uganda. Our estimate for fext in
Rakai agreed nicely with the data from the Rakai Study. In this
setting, HIV population-level incidence rate (λ) was reported to
be 1.5 per 100 person-years,11 and the annual risk of HIV trans-
mission within an SDC (ϕ) to be 9.2 per 100 person-years.12
Accordingly using our model, the contribution of external infec-
tions to HIV incidence among SDCs is estimated at 14%.
Phylogenetic analysis was performed in the Rakai Study, by
sequencing the gag (p24) and gp41 regions, to establish the level
of HIV viral linkage within the couples, and accordingly estimate
fext.13 It was found that 86% of HIV transmissions were strongly
or moderately linked.13 This suggests that fext is of the order of
15%, a value that is, in close agreement with our estimate.
The strong dependence of fext on HIV prevalence is easily
understood considering that λ depends on the likelihood of
forming a partnership with an HIV infected individual, and
that the probability of selecting at random an HIV infected
individual in a given population, that is, HIV population preva-
lence, varies widely across SSA. Indeed, it is 50 times higher in
Lesotho, with an HIV prevalence of 23.0%, compared to
Senegal, with an HIV prevalence of only 0.5%.
Although ϕ and λ vary across the countries, these variations
had minimal impact on our conclusion that fext is overall small
except in countries at high HIV prevalence (see eg, online
supplementary ﬁgure S1). It bears notice that our country-speciﬁc
estimates for ϕ are consistent with available empirical measures
and are at the mid-range of the reported values.8–10
Our ﬁndings suggest that the values found recently in
RCTs1 2 are not representative of the population-based fext
in the majority of countries. Sero-status disclosure, intensive
counselling, and access to prevention methods may explain the
larger fext in RCTs. For instance, sero-disclosure in the Partners
in Prevention RCT resulted in a reduction in sexual activity
within the SDC and an increased engagement of the uninfected
partners in external partnerships.14 This is afﬁrmed by the
low HIV incidence rate among SDCs that has been reported in
these RCTs (∼2 per 100 person-years),1 2 which is much smaller
than that observed in observational studies (∼10 per 100 person-
years).8 10 These considerations indicate that the large values
of fext reported in these RCTs are on the extreme end of the
actual values for fext in the wider population across SSA.
The essential assumption in our methodology is that the risk
of infection from external sources does not vary substantially
based on the individual’s marital status, or engagement in a
concordant negative couple versus an SDC. The validity of this
assumption is not known, but empirical data from the Rakai
Study suggests its plausibility. In Rakai, the risk of HIV acquisi-
tion per person was 0.5% (95% CI 0.3% to 0.8%) in round I
prior to antiretroviral therapy availability among persons in
concordant negative couples, versus 0.7% (95% CI 0.4% to
1.0%) among unmarried persons (over about 14 months of
follow-up). These estimates were calculated from the data in
Gray et al.5 In round II post antiretroviral therapy availability, it
was 0.7% (95% CI 0.5% to 0.9%) versus 1.1% (95% CI 0.8% to
1.4%) (over about 18 months of follow-up). These values
suggest that the risk of external infection among persons in
stable couples is comparable, though possibly somewhat lower,
than those among unmarried persons. If married persons
engage in less extra-marital sex than unmarried persons, this
would further lower our fext estimates.
On the other hand, it is reasonable to assume that HIV
sero-status disclosure can increase the risk of external infection
among SDCs in comparison to concordant negative stable
couples.14 However, the low levels of condom use at last sex
reported by the couples in the DHS databases (table S1 of
SOA) suggest that sero-disclosure is rather limited in the wider
population in SSA. Hence, the actual current levels of sero-
disclosure in SSA are not likely to affect our conclusion.
The risk of acquiring HIV from external sources may vary by
age, since HIV incidence rate is strongly dependent on age, and
thus may affect our estimates for fext. We examined the age dis-
tribution of SDCs across the SSA countries included in our ana-
lysis. The mean age of females in SDCs was found overall to be
in the range of 25–35 years with an average over countries
of 30.5 years. As for males, it was overall in the range of
35–45 years with an average over countries of 38.7 years. These
results were invariable regardless of whether the index partner
was a female or a male. By comparing these age distributions
to empirical measures of HIV incidence-rate age distribution
across different settings in SSA,15 16 we found that HIV inci-
dence rate among these SDCs age groups to be substantially
lower than that in the younger age groups and comparable to
the overall HIV incidence rate. Indeed, close to half of all HIV
infections in SSA are among those younger than 25 years of
age, and females acquire HIV at an earlier age group than
males.15–17 These considerations suggest that it is unlikely that
the variability in the age distribution of HIV incidence rate will
noticeably affect our analysis.
A fraction of HIV population-level incidence rate arises from
the incidence of HIV among SDCs. Eliminating this contribu-
tion from HIV population incidence rate would further reduce
the likelihood of acquiring HIV from external sources among
SDCs and hence lower our estimates for fext. This further sug-
gests that our estimates for fext are more likely to overestimate
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rather than underestimate the actual contribution of external
infections among SDCs.
On balance, the discussion above suggests the overall validity
of our assumptions. Moreover, even considerable deviations to
these assumptions are not likely to affect our conclusion of
modest role for external infections as shown in the sensitivity
analyses (ﬁgure 1B and online supplementary ﬁgure S1).
To sum up, fext varies substantially across SSA, but is gener-
ally below 10% in most countries. Only in hyperendemic HIV
epidemics the contribution of external infections is sizable and
may reach up to 30%. The vast majority of HIV acquisitions
among SDCs are transmissions from the infected to the suscep-
tible partner. These ﬁndings however should not be over-
interpreted to believe that HIV incidence within SDCs domi-
nates HIV incidence in the population.
Key messages
▸ Nearly all of HIV incidence among stable HIV-1 sero-discordant
couples (SDCs) in most countries in sub-Saharan Africa (SSA)
appears to be attributed to HIV transmission from the infected
to the uninfected partner in the couple.
▸ The fraction of externally acquired HIV infections among stable
HIV-1 SDCs strongly depends on HIV prevalence in the
population and varies across SSA.
▸ Only in hyperendemic HIV epidemics, the contribution of
external infections among stable HIV-1 SDCs is sizable and
may reach up to 30%.
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